Why Are Shares Of IO Biotech Plummeting?
IO Biotech shares are trading lower after the company announced it filed for Chapter 7 bankruptcy and will cease operations in Delaware.
IO Biotech Files Chapter 7 Bankruptcy And Ceases Operations In Delaware; Common Stockholders Unlikely To Receive Payment Or Distribution After Bankruptcy; Terminates All Employees And Officers Including CEO And CFO
Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending
Here's Why IO Biotech, Inc. (IOBT) Looks Ripe for Bottom Fishing
12 Health Care Stocks Moving In Friday's Pre-Market Session
IO Biotech Provides Corporate Update
IO Biotech Implements Cost-Containment And Cash Conservation Measures, Including Workforce Reduction, To Lessen Operating Expenses While Exploring Strategic Alternatives
Piper downgrades IO Biotech amid strategic alternatives evaluation
IO Biotech shares are trading lower after Piper Sandler downgraded the stock from Overweight to Neutral and cut its price target from $3 to $0.5.
Piper Sandler Downgrades IO Biotech to Neutral, Lowers Price Target to $0.5
IO Biotech shares are trading lower. The company announced plans to explore strategic alternatives, including a merger, asset sale, business combination, or liquidation, while also considering workforce reductions and other cost-cutting measures to maximize stockholder value.
IO Biotech Announces Exploration of Strategic Alternatives
IO Biotech Considers Strategic Options, Including Possible Sale or Wind-Down
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
IO Biotech Announces Publication In Nature Communications Of Long-Term Clinical And Immunological Outcomes From Phase 1/2 Trial MM1636
IO Biotech Announces Participation in Upcoming December Investor Conferences
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.